
Comparative Cancer Incidence by Organ Site in Rheumatoid Arthritis Treated with Janus Kinase Inhibitors versus Tumor ...
Introduction Janus kinase inhibitors (JAKi) are effective and approved therapies for myeloproliferative disorders, rheumatoid arthritis (RA), psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, alopecia areata, and in patients hospitalized for …